Could the Tampa Bay Rays be on the verge of trading one of their most reliable bullpen arms? Garrett Cleavinger, the left-handed reliever who has been a cornerstone of the Rays' bullpen, is reportedly drawing significant trade interest from teams seeking to bolster their late-inning options. But here’s where it gets intriguing: while Cleavinger’s name is circulating in trade talks, there’s no clear indication that a deal is imminent. So, what’s the real story behind this potential move?
Cleavinger, who turns 32 in April, is entering his seventh MLB season and his fourth full year with the Rays. Acquired from the Dodgers at the 2022 trade deadline, he’s become a prime example of how the Rays’ pitching development system can elevate a player’s performance. Since joining Tampa Bay, Cleavinger has posted a stellar 2.96 ERA over 152 relief innings, proving himself as a dependable option against both left-handed and right-handed batters. His 2025 campaign was particularly impressive, with a 2.35 ERA, a 33.7% strikeout rate, and a 7.4% walk rate across 61 1/3 innings. Statcast metrics backed up his success, showing elite strikeout and whiff rates, along with a favorable .244 BABIP and a remarkable 91.6% strand rate.
But here’s where it gets controversial: While Cleavinger’s 2025 performance was undeniably strong, some might argue that his numbers were boosted by favorable luck. However, a closer look reveals that his success was largely sustainable, making him a valuable asset for any team—including the Rays. Even if Tampa Bay were to trade him now, there’s little reason to doubt that Cleavinger would continue to thrive in 2026 and beyond. The Rays, known for their willingness to engage in trade talks for virtually any player, might see this as an opportunity to sell high. Yet, with Cleavinger earning just $2.4MM in 2026 and only one year of arbitration eligibility remaining, he’s a bargain for his production. Plus, his importance to the Rays’ bullpen—especially as their only left-handed reliever—makes a trade less likely unless the offer is truly exceptional.
And this is the part most people miss: The Rays don’t have a designated closer heading into the 2026 season. Cleavinger, along with Edwin Uceta, Griffin Jax, and Bryan Baker, is expected to share save opportunities. While one of them could emerge as the primary closer, Cleavinger’s role as a situational lefty might limit his save chances. This dynamic, combined with the lack of left-handed relief depth, further complicates the idea of trading him. Speaking of the bullpen, Uceta is currently dealing with minor shoulder soreness, though manager Kevin Cash assures it’s not a serious concern. Meanwhile, Cleavinger and Jax are set to represent the United States in the World Baseball Classic, showcasing their talent on an international stage.
So, should the Rays trade Cleavinger now, or hold onto him as a key piece of their bullpen? What do you think? Is this the right time to capitalize on his value, or would letting him go weaken the team’s late-inning strategy? Let us know in the comments below!
